Claire S Allardyce1, Paul J Dyson
1Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland. paul.dyson@epfl.ch.
Platinum compounds like cisplatin are vital cancer treatments, but their success has limited new drug discovery. This perspective explores alternative metal-based anticancer drugs and future design strategies beyond platinum.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: